Global Cell and Gene Therapy Solutions Supply, Demand and Key Producers, 2024-2030

Description

The global Cell and Gene Therapy Solutions market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The field of cell and gene therapy is currently in a phase of robust growth, with an expanding market size. As scientific advancements continue, the application scope of cell and gene therapies is widening, encompassing the treatment of various diseases such as cancer, genetic disorders, and autoimmune conditions. Sales within this sector are on a consistent upward trajectory, reflecting significant commercial potential. While some remarkable successes have been achieved in the realm of cell and gene therapy, challenges concerning safety and regulatory compliance persist. Looking ahead, as research deepens, it is anticipated that the field will continue to make breakthroughs, ushering in more innovation and transformative changes within the medical domain.

Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.

This report studies the global Cell and Gene Therapy Solutions demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Solutions, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Solutions that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Solutions total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy Solutions total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy Solutions total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Solutions revenue by player and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy Solutions total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy Solutions total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy Solutions market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis, Biomarin Pharmaceutical, Uniqure, Spark Therapeutics, Alaunos Therapeutics and Homology Medicines, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Solutions market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy Solutions Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Solutions Market, Segmentation by Type
    Stem Cell Therapy
    Gene Therapy
    Other

Global Cell and Gene Therapy Solutions Market, Segmentation by Application
    Neurological Diseases
    Cancer
    Other

Companies Profiled:
    Bluebird Bio
    Sarepta Therapeutics
    Solid Biosciences
    Novartis
    Biomarin Pharmaceutical
    Uniqure
    Spark Therapeutics
    Alaunos Therapeutics
    Homology Medicines
    Biogen
    Legend Biotech
    CARsgen

Key Questions Answered
1. How big is the global Cell and Gene Therapy Solutions market?
2. What is the demand of the global Cell and Gene Therapy Solutions market?
3. What is the year over year growth of the global Cell and Gene Therapy Solutions market?
4. What is the total value of the global Cell and Gene Therapy Solutions market?
5. Who are the major players in the global Cell and Gene Therapy Solutions market?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Solutions Introduction
    1.2 World Cell and Gene Therapy Solutions Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy Solutions Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Solutions Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.3 China Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.4 Europe Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.5 Japan Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.6 South Korea Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.7 ASEAN Cell and Gene Therapy Solutions Market Size (2019-2030)
        1.3.8 India Cell and Gene Therapy Solutions Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Solutions Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Solutions Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy Solutions Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Solutions Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy Solutions Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy Solutions Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy Solutions Consumption Value (2019-2030)

3 World Cell and Gene Therapy Solutions Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Solutions Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Solutions Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Solutions in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Solutions in 2023
    3.3 Cell and Gene Therapy Solutions Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Solutions Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Solutions Market: Region Footprint
        3.4.2 Cell and Gene Therapy Solutions Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Solutions Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Solutions Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Solutions Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Solutions Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Solutions Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Solutions Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy Solutions Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy Solutions Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy Solutions Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy Solutions Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy Solutions Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy Solutions Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy Solutions Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Solutions Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Stem Cell Therapy
        5.2.2 Gene Therapy
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Solutions Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy Solutions Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy Solutions Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Solutions Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Neurological Diseases
        6.2.2 Cancer
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Solutions Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy Solutions Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy Solutions Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bluebird Bio
        7.1.1 Bluebird Bio Details
        7.1.2 Bluebird Bio Major Business
        7.1.3 Bluebird Bio Cell and Gene Therapy Solutions Product and Services
        7.1.4 Bluebird Bio Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bluebird Bio Recent Developments/Updates
        7.1.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.2 Sarepta Therapeutics
        7.2.1 Sarepta Therapeutics Details
        7.2.2 Sarepta Therapeutics Major Business
        7.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Product and Services
        7.2.4 Sarepta Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sarepta Therapeutics Recent Developments/Updates
        7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.3 Solid Biosciences
        7.3.1 Solid Biosciences Details
        7.3.2 Solid Biosciences Major Business
        7.3.3 Solid Biosciences Cell and Gene Therapy Solutions Product and Services
        7.3.4 Solid Biosciences Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Solid Biosciences Recent Developments/Updates
        7.3.6 Solid Biosciences Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Cell and Gene Therapy Solutions Product and Services
        7.4.4 Novartis Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Biomarin Pharmaceutical
        7.5.1 Biomarin Pharmaceutical Details
        7.5.2 Biomarin Pharmaceutical Major Business
        7.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product and Services
        7.5.4 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Biomarin Pharmaceutical Recent Developments/Updates
        7.5.6 Biomarin Pharmaceutical Competitive Strengths & Weaknesses
    7.6 Uniqure
        7.6.1 Uniqure Details
        7.6.2 Uniqure Major Business
        7.6.3 Uniqure Cell and Gene Therapy Solutions Product and Services
        7.6.4 Uniqure Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Uniqure Recent Developments/Updates
        7.6.6 Uniqure Competitive Strengths & Weaknesses
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Details
        7.7.2 Spark Therapeutics Major Business
        7.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Product and Services
        7.7.4 Spark Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Spark Therapeutics Recent Developments/Updates
        7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.8 Alaunos Therapeutics
        7.8.1 Alaunos Therapeutics Details
        7.8.2 Alaunos Therapeutics Major Business
        7.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Product and Services
        7.8.4 Alaunos Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Alaunos Therapeutics Recent Developments/Updates
        7.8.6 Alaunos Therapeutics Competitive Strengths & Weaknesses
    7.9 Homology Medicines
        7.9.1 Homology Medicines Details
        7.9.2 Homology Medicines Major Business
        7.9.3 Homology Medicines Cell and Gene Therapy Solutions Product and Services
        7.9.4 Homology Medicines Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Homology Medicines Recent Developments/Updates
        7.9.6 Homology Medicines Competitive Strengths & Weaknesses
    7.10 Biogen
        7.10.1 Biogen Details
        7.10.2 Biogen Major Business
        7.10.3 Biogen Cell and Gene Therapy Solutions Product and Services
        7.10.4 Biogen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Biogen Recent Developments/Updates
        7.10.6 Biogen Competitive Strengths & Weaknesses
    7.11 Legend Biotech
        7.11.1 Legend Biotech Details
        7.11.2 Legend Biotech Major Business
        7.11.3 Legend Biotech Cell and Gene Therapy Solutions Product and Services
        7.11.4 Legend Biotech Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Legend Biotech Recent Developments/Updates
        7.11.6 Legend Biotech Competitive Strengths & Weaknesses
    7.12 CARsgen
        7.12.1 CARsgen Details
        7.12.2 CARsgen Major Business
        7.12.3 CARsgen Cell and Gene Therapy Solutions Product and Services
        7.12.4 CARsgen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 CARsgen Recent Developments/Updates
        7.12.6 CARsgen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Solutions Industry Chain
    8.2 Cell and Gene Therapy Solutions Upstream Analysis
    8.3 Cell and Gene Therapy Solutions Midstream Analysis
    8.4 Cell and Gene Therapy Solutions Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Solutions Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Solutions Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Solutions Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Solutions Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Solutions Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Solutions Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cell and Gene Therapy Solutions Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cell and Gene Therapy Solutions Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cell and Gene Therapy Solutions Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Solutions Players in 2023
    Table 12. World Cell and Gene Therapy Solutions Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cell and Gene Therapy Solutions Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Solutions Player
    Table 15. Cell and Gene Therapy Solutions Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Solutions Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Solutions Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Solutions Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Solutions Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Solutions Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Solutions Revenue Market Share (2019-2024)
    Table 23. China Based Cell and Gene Therapy Solutions Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Solutions Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cell and Gene Therapy Solutions Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Solutions Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Solutions Revenue Market Share (2019-2024)
    Table 29. World Cell and Gene Therapy Solutions Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cell and Gene Therapy Solutions Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cell and Gene Therapy Solutions Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cell and Gene Therapy Solutions Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cell and Gene Therapy Solutions Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cell and Gene Therapy Solutions Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bluebird Bio Basic Information, Area Served and Competitors
    Table 36. Bluebird Bio Major Business
    Table 37. Bluebird Bio Cell and Gene Therapy Solutions Product and Services
    Table 38. Bluebird Bio Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bluebird Bio Recent Developments/Updates
    Table 40. Bluebird Bio Competitive Strengths & Weaknesses
    Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 42. Sarepta Therapeutics Major Business
    Table 43. Sarepta Therapeutics Cell and Gene Therapy Solutions Product and Services
    Table 44. Sarepta Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Sarepta Therapeutics Recent Developments/Updates
    Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 47. Solid Biosciences Basic Information, Area Served and Competitors
    Table 48. Solid Biosciences Major Business
    Table 49. Solid Biosciences Cell and Gene Therapy Solutions Product and Services
    Table 50. Solid Biosciences Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Solid Biosciences Recent Developments/Updates
    Table 52. Solid Biosciences Competitive Strengths & Weaknesses
    Table 53. Novartis Basic Information, Area Served and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Cell and Gene Therapy Solutions Product and Services
    Table 56. Novartis Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Novartis Competitive Strengths & Weaknesses
    Table 59. Biomarin Pharmaceutical Basic Information, Area Served and Competitors
    Table 60. Biomarin Pharmaceutical Major Business
    Table 61. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product and Services
    Table 62. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Biomarin Pharmaceutical Recent Developments/Updates
    Table 64. Biomarin Pharmaceutical Competitive Strengths & Weaknesses
    Table 65. Uniqure Basic Information, Area Served and Competitors
    Table 66. Uniqure Major Business
    Table 67. Uniqure Cell and Gene Therapy Solutions Product and Services
    Table 68. Uniqure Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Uniqure Recent Developments/Updates
    Table 70. Uniqure Competitive Strengths & Weaknesses
    Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 72. Spark Therapeutics Major Business
    Table 73. Spark Therapeutics Cell and Gene Therapy Solutions Product and Services
    Table 74. Spark Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Spark Therapeutics Recent Developments/Updates
    Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 77. Alaunos Therapeutics Basic Information, Area Served and Competitors
    Table 78. Alaunos Therapeutics Major Business
    Table 79. Alaunos Therapeutics Cell and Gene Therapy Solutions Product and Services
    Table 80. Alaunos Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Alaunos Therapeutics Recent Developments/Updates
    Table 82. Alaunos Therapeutics Competitive Strengths & Weaknesses
    Table 83. Homology Medicines Basic Information, Area Served and Competitors
    Table 84. Homology Medicines Major Business
    Table 85. Homology Medicines Cell and Gene Therapy Solutions Product and Services
    Table 86. Homology Medicines Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Homology Medicines Recent Developments/Updates
    Table 88. Homology Medicines Competitive Strengths & Weaknesses
    Table 89. Biogen Basic Information, Area Served and Competitors
    Table 90. Biogen Major Business
    Table 91. Biogen Cell and Gene Therapy Solutions Product and Services
    Table 92. Biogen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Biogen Recent Developments/Updates
    Table 94. Biogen Competitive Strengths & Weaknesses
    Table 95. Legend Biotech Basic Information, Area Served and Competitors
    Table 96. Legend Biotech Major Business
    Table 97. Legend Biotech Cell and Gene Therapy Solutions Product and Services
    Table 98. Legend Biotech Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Legend Biotech Recent Developments/Updates
    Table 100. CARsgen Basic Information, Area Served and Competitors
    Table 101. CARsgen Major Business
    Table 102. CARsgen Cell and Gene Therapy Solutions Product and Services
    Table 103. CARsgen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 104. Global Key Players of Cell and Gene Therapy Solutions Upstream (Raw Materials)
    Table 105. Cell and Gene Therapy Solutions Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Solutions Picture
    Figure 2. World Cell and Gene Therapy Solutions Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cell and Gene Therapy Solutions Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cell and Gene Therapy Solutions Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Solutions Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Solutions Revenue (2019-2030) & (USD Million)
    Figure 13. Cell and Gene Therapy Solutions Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cell and Gene Therapy Solutions Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cell and Gene Therapy Solutions Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Solutions by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Solutions Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Solutions Markets in 2023
    Figure 27. United States VS China: Cell and Gene Therapy Solutions Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cell and Gene Therapy Solutions Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cell and Gene Therapy Solutions Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cell and Gene Therapy Solutions Market Size Market Share by Type in 2023
    Figure 31. Stem Cell Therapy
    Figure 32. Gene Therapy
    Figure 33. Other
    Figure 34. World Cell and Gene Therapy Solutions Market Size Market Share by Type (2019-2030)
    Figure 35. World Cell and Gene Therapy Solutions Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Cell and Gene Therapy Solutions Market Size Market Share by Application in 2023
    Figure 37. Neurological Diseases
    Figure 38. Cancer
    Figure 39. Other
    Figure 40. Cell and Gene Therapy Solutions Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen